Generic drugmaker says it was pushed to be paid to delay
Credit: iStock/ Savushkin
Generics UK had “little choice” but to enter into a settlement with GlaxoSmithKline in an alleged pay-for-delay scheme, counsel to the generic drugmaker told the Competition Appeal Tribunal today.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now